During the past decade, Peninsula Oncology Centre conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 10 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peninsula Oncology Centre" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Canadian Cancer Trials Group" with 2 trials sponsored, "Celgene" with 2 trials sponsored, "Sirtex Medical" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peninsula Oncology Centre" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 1 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Peninsula Oncology Centre" are "Non-Small Cell Lung Cancer" (2 trials), "B-cell Lymphoma" (1 trials), "Breast Cancer" (1 trials), "Castration-Resistant Prostate Cancer" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Peninsula Oncology Centre" in a lesser frequency.

Most popular intervention types in "Peninsula Oncology Centre" are "Drug" (20 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Cyclophosphamide" (4 trials), "Rituximab" (3 trials), "Doxorubicin" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Peninsula Oncology Centre" are 18 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Peninsula Oncology Centre". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Peninsula Oncology Centre, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Peninsula Oncology Centre, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".